Gene diagnosis of micrometastases in regional lymph nodes of patients with stage I non-small cell lung cancer: Impact on staging and prognosis

Clinical and Translational Oncology

Volumn 15, Issue 11, 2013, Pages 882-888

  Li, J ^a   Li, Z N ^b   Yu, L C ^a   Shi, S B ^a   Ge, L P ^a   Wu, J R ^a   Hu, Y M ^a  

^a AFFILIATED HOSPITAL OF JIANGSU UNIVERSITY   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Livin; Lymph node; Micrometastasis; Non small cell lung cancer; Survivin

Indexed keywords

LIVIN; MESSENGER RNA; SURVIVIN;

ADULT; AGED; ARTICLE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; MICROMETASTASIS; OVERALL SURVIVAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADULT; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM MICROMETASTASIS; NEOPLASM PROTEINS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84886598898     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-013-1017-1     Document Type: Article

References (30)

1. Rena O, Oliaro A, Cavallo A, Filosso PL, Donati G, Di Marzio P et al (2002) Stage I non-small cell lung carcinoma. Really an early stage? Eur J Cardio-Thorac Surg 21:514-519 (Pubitemid 34224811)
2. Mountain CF (1997) Revisions in the international system for stage lung cancer. Chest 111:1710-1717 (Pubitemid 27260107)
3. Rena O, Carsana L, Cristina S, Papalia E, Massera F, Errico L et al (2007) Lymph node isolated tumor cells and micrometastases in pathological stage I non-small cell lung cancer: prognostic significance. Eur J Cardio-Thorac Surg 32:863-867 (Pubitemid 350052580)
4. Gu CD, Osaki T, Oyama T, Inoue M, Kodate M, Dobashi K et al (2002) Detection of micrometastatic tumor-cells in pN0 lymph nodes of patients with completely resected non-small cell lung cancer: impact on recurrence and survival. Ann Surg 235:133-139 (Pubitemid 34062409)
5. Wu J, Ohta Y, Minato H, Tsunezuka Y, Oda M, Watanabe Y et al (2001) Nodal occult metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg 7:1772-1777 (Pubitemid 32554396)
6. Le Pimpec-Barthes F, Danel C, Lacave R, Ricci S, Bry X, Lancelin F et al (2005) Association of CK 19 mRNA detection of occult cancer cells in mediastinal lymph nodes in non-small cell lung carcinoma and high risk of early recurrence. Eur J Cancer 41:306-312 (Pubitemid 40126964)
7. Marchevsky AM, Qiao JH, Krajisnik S, Mirocha JM, Mckenna RJ (2003) The prognostic significance of intranodal isolated tumor cells and micrometastases in patients with non-small cell lung carcinoma of the lung. J Thorac Cardiovasc Surg 126:551-557 (Pubitemid 37048525)
8. Osaki T, Oyama T, Gu CD, Yamashita T, So T, Takenoyama M et al (2002) Prognostic impact of micrometastatic tumor cells in the lymph nodes and bone marrow of patients with completely resected stage I non-small cell lung cancer. J Clin Oncol 13:2930-2936 (Pubitemid 34728886)
9. Salerno CT, Frizelle S, Niehans GA, Ho SB, Jakkula M, Kratzke RA et al (1998) Detection of occult micrometastases in non-small cell lung carcinoma by reverse transcriptas-polymerase chain reaction. Chest 113:1526-1532 (Pubitemid 28307155)
10. Mori M, Mimori K, Inoue H, Barnard GF, Tsuji K, Nanbara S et al (1995) Detection of cancer micrometastases in lymph nodes by reverse transcriptagepolymeras chain reaction. Cancer Res 55:3417-3420
11. Noguchi S, Aihara T, Motomura K, Inaji H, Imaoka S, Koyama H (1996) Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Am J Pathol 148:649-656
12. Ambrosini G, Adida C, Altieri DC (1997) A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 3:917-921 (Pubitemid 27353455)
13. Altieri DC (2003) Survivin, versatile modulation of cell division and apoptosis in cancer. Oncogene 22:8581-8589 (Pubitemid 38019195)
14. Kasof GM, Gomes BC (2001) Livin, a novel inhibitor of apoptosis protein family member. J Bio Chem 276:3238-3246
15. Velculescu VE, Madden SL, Zhang L Lash AE, Yu J, Rago CL et al (1999) Analysis of human transcriptomes. Nat Genet 23:387-388
16. Altieri DC (2001) The molecular basis and potential role of survivin in cancer diagnosis and therapy. Trends Mol Med 7:542-547 (Pubitemid 33127139)
17. Altieri DC (2003) Validating survivin as a cancer therapeutic target. Nat Rev Cancer 3:46-54 (Pubitemid 37328886)
18. Dai CH, Li J, Shi SB, Yu LC, Ge LP, Chen P (2010) Survivin and smac gene expressions but not livin are predictors of prognosis in non-small cell lung cancer patients treated with adjuvant chemotherapy following surgery. Jpn J Clin Oncol 40:327-335
19. Chen P, Li J, Ge L-P, Dai C-H, Li X-Q (2010) Prognostic value of survivin, X-linked inhibitor of apoptosis protein and second mitochondria-derived activator of caspases expression in advanced non-small-cell lung cancer patients. Respirology 15:501-509
20. Vucic D, Stennicke HR, Pisabarro MT, Salvesen GS, Dixit VM (2000) ML-IAP, a novel inhibitor of apoptosis that is preferentially expressed in human melanomas. Curr Biol 10:1359-1366
21. Tanabe H, Yagidashi A, Tsuji N, Shijubo Y, Abe S, Watanabe N (2004) Expression of survivin mRNA and livin mRNA in non-small cell lung cancer. Lung Cancer 46:299-304 (Pubitemid 39487304)
22. Gazzanige P, Gradilone A, Giuliani L, Gandini O, Silvestri I, Nofroni I et al (2003) Expression and prognostic significance of livin, survivin and other apoptosis related genes in the progression of superficial bladder cancer. Ann Oncol 14:85-90 (Pubitemid 36150264)
23. Xiang Y, Yao H, Wang S, Hong M, He J, Cao S et al (2006) Prognostic value of survivin and livin in nasopharyngeal carcinoma. Laryngoscope 116:126-130 (Pubitemid 44383976)
24. American Thoracic Society (1983) Clinical staging of primary lung cancer. Am Rev Respir Dis 127:659
25. Lugo TG, Braun S, Cote RJ, Panted K, Rusch V (2003) Detection and measurement of occult disease for the prognosis of solid tumors. J Clin Oncol 21:2609-2615 (Pubitemid 46606345)
26. Kappler M, Kohler T, Kampf C, Diestelkötter, P, Würl, P, Schmitz M et al (2001) Increased survivin transcript levels: an independent negative predictor of survival in soft tissue sarcoma patients. Int J Cancer 95:360-363 (Pubitemid 33015105)
27. Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R et al (2001) Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 32:119-125 (Pubitemid 32150638)
28. Zippelius A, Kufer P, Honold G, Köllermann MW, Oberneder R, Schlimok G et al (1997) Limitations of revers-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15:2701-2708 (Pubitemid 27289903)
29. Cao M, Yie SM, Wu SM, Chen S, Lou B, He X et al (2009) Detection of survivin-expressing circulating cancer cells in the peripheral blood of patients with esophageal squamous cell carcinoma and its clinical significance. Clin Exp Metastasis 26:751-758
30. Yang D, Schneider S, Azuma M, Iqbal S, El-Khoueiry A, Groshen S et al (2006) Gene expression levels of epidermal growth factor receptor, survivin, and vascular endothelial growth factor as molecular markers of lymph node involvement in patients with locally advanced rectal cancer. Clin Colorect Cancer 6:305-311 (Pubitemid 46157480)